Iovance Biotherapeutics (IOVA) Leases: 2019-2025
Historic Leases for Iovance Biotherapeutics (IOVA) over the last 3 years, with Sep 2025 value amounting to $48.8 million.
- Iovance Biotherapeutics' Leases was N/A to $48.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.8 million, marking a year-over-year change of. This contributed to the annual value of $55.2 million for FY2024, which is 11.70% down from last year.
- As of Q3 2025, Iovance Biotherapeutics' Leases stood at $48.8 million, which was down 2.37% from $49.9 million recorded in Q2 2025.
- Iovance Biotherapeutics' 5-year Leases high stood at $71.5 million for Q1 2024, and its period low was $48.8 million during Q3 2025.
- In the last 3 years, Iovance Biotherapeutics' Leases had a median value of $62.5 million in 2023 and averaged $60.4 million.
- In the last 5 years, Iovance Biotherapeutics' Leases rose by 1.54% in 2024 and then dropped by 28.82% in 2025.
- Iovance Biotherapeutics' Leases (Quarterly) stood at $62.5 million in 2023, then dropped by 11.70% to $55.2 million in 2024, then fell by 28.82% to $48.8 million in 2025.
- Its last three reported values are $48.8 million in Q3 2025, $49.9 million for Q2 2025, and $50.9 million during Q1 2025.